000 | 01966 a2200541 4500 | ||
---|---|---|---|
005 | 20250515005428.0 | ||
264 | 0 | _c20060105 | |
008 | 200601s 0 0 eng d | ||
022 | _a0038-4348 | ||
024 | 7 |
_a10.1097/01.smj.0000184921.53062.bf _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHamdy, Ronald C | |
245 | 0 | 0 |
_aReview of treatment modalities for postmenopausal osteoporosis. _h[electronic resource] |
260 |
_bSouthern medical journal _cOct 2005 |
||
300 |
_a1000-14; quiz 1015-7, 1048 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAlendronate _xtherapeutic use |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
650 | 0 | 4 |
_aCalcium _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDiet |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
650 | 0 | 4 |
_aEtidronic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aExercise _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFish Oils _xadministration & dosage |
650 | 0 | 4 |
_aHip Fractures _xetiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIbandronic Acid |
650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xcomplications |
650 | 0 | 4 |
_aRaloxifene Hydrochloride _xtherapeutic use |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisedronic Acid |
650 | 0 | 4 |
_aTeriparatide _xtherapeutic use |
650 | 0 | 4 |
_aVitamin D _xadministration & dosage |
650 | 0 | 4 |
_aVitamin D Deficiency _xdrug therapy |
700 | 1 | _aChesnut, Charles H | |
700 | 1 | _aGass, Margery L | |
700 | 1 | _aHolick, Michael F | |
700 | 1 | _aLeib, Edward S | |
700 | 1 | _aLewiecki, Michael E | |
700 | 1 | _aMaricic, Michael | |
700 | 1 | _aWatts, Nelson B | |
773 | 0 |
_tSouthern medical journal _gvol. 98 _gno. 10 _gp. 1000-14; quiz 1015-7, 1048 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.smj.0000184921.53062.bf _zAvailable from publisher's website |
999 |
_c15919674 _d15919674 |